Silverarc Capital Management, LLC Scholar Rock Holding Corp Transaction History

Silverarc Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$13.2 - $17.76 $931,722 - $1.25 Million	-70,585 Reduced 26.14%	199,415 $3.54 Million
Q4 2023 Feb 14, 2024	BUY	$6.52 - $20.32 $1.7 Million - $5.29 Million	260,289 Added 2680.35%	270,000 $5.08 Million
Q3 2023 Nov 13, 2023	BUY	$6.02 - $7.76 $58,460 - $75,357	9,711 New	9,711 $68,000
Q2 2021 Aug 16, 2021	SELL	$26.34 - $46.62 $954,061 - $1.69 Million	-36,221 Closed	0 $0
Q1 2021 May 18, 2021	BUY	$45.96 - $68.02 $515,717 - $763,252	11,221 Added 44.88%	36,221 $1.84 Million
Q4 2020 Feb 16, 2021	BUY	$13.72 - $51.57 $343,000 - $1.29 Million	25,000 New	25,000 $1.21 Million

175

75.6M

585K

862K

Ticker SRRK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,640,600
Market Cap $2.17B
Description
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...

Get notified when there are updates to the investment portfolio of Silverarc Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Silverarc Capital Management, LLC with notifications on news.